s6y
Company name or ticker
Search
Raphael Pharmaceutical Inc.
8-K
Current report filing
Filed
Friday, July 17, 2026
Period
Jul 16, 2026
Accession number
0001213900-26-078937
Documents
CURRENT REPORT
8-K
XBRL SCHEMA FILE
EX-101.SCH
XBRL LABEL FILE
EX-101.LAB
XBRL PRESENTATION FILE
EX-101.PRE
On sec.gov
Filing index
All files
Complete submission text
SGML header